Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles 2022: Biology, Disease & Medicine

Julie Saugstad's Biography



Julie Saugstad, Professor, Department of Anesthesiology & Perioperative Medicine, Oregon Health & Science University

Dr. Saugstad earned her BS in Microbiology from Oklahoma State University, her PhD in Biochemistry & Molecular Biology from the University of Oklahoma Health Sciences Center, and trained as a Postdoctoral Fellow at the Vollum Institute at the Oregon Health & Science University (OHSU). She is a Professor in the Department of Anesthesiology and Perioperative Medicine, and an affiliate faculty member in the Departments of Molecular and Medical Genetics, and Neurology at the OHSU.

Funded by the 1st NIH Extracellular RNA Communication Program, her team discovered and validated miRNA biomarkers for Alzheimer’s disease (AD) in cerebrospinal fluid (CSF) from living donors, then identified miRNAs that trend with progression from control to mild cognitive impairment (MCI) to AD. Current studies are establishing whether the CSF miRNAs can discriminate AD from controls in plasma, whether the trending CSF miRNAs relevant to MCI are changed in plasma, and whether the CSF miRNAs are specific for AD vs. other neurodegenerative diseases. Her team has also shown differential effect of two biological factors for AD, APOE genotype and sex, on extracellular vesicle (EV) cargo, which may influence AD pathophysiology.

Julie Saugstad Image

Differential Effects of APOE Genotype on Cerebrospinal Fluid Extracellular Vesicle miRNAs in Females vs. Males with Alzheimer's Disease

Wednesday, 14 September 2022 at 15:30

Add to Calendar ▼2022-09-14 15:30:002022-09-14 16:30:00Europe/LondonDifferential Effects of APOE Genotype on Cerebrospinal Fluid Extracellular Vesicle miRNAs in Females vs. Males with Alzheimer's DiseaseExtracellular Vesicles 2022: Biology, Disease and Medicine in SeattleSeattleSELECTBIOenquiries@selectbiosciences.com

Alzheimer’s disease (AD) is the most common form of dementia and the sixth-leading cause of death in the United States. We identified and validated miRNA biomarkers for Alzheimer's disease (AD) in cerebrospinal fluid (CSF) from living donors, then showed that five of the AD miRNAs trend down in expression from controls to mild cognitive impairment to AD. Our recent studies revealed that two biological risk factors for AD, sex and APOE e4 genotype, differentially effect CSF EV miRNA levels: APOE e4 within each sex altered distinct miRNAs, and predicted gene targets and pathways of the altered miRNAs are known to contribute to neurodegeneration in AD. We are currently establishing the physical features and molecular cargo of AD CSF EVs within the context of APOE genotype and sex, with the goal to identify novel gene targets of CSF EV miRNAs that are relevant to AD pathophysiology.


Add to Calendar ▼2022-09-13 00:00:002022-09-14 00:00:00Europe/LondonExtracellular Vesicles 2022: Biology, Disease and MedicineExtracellular Vesicles 2022: Biology, Disease and Medicine in SeattleSeattleSELECTBIOenquiries@selectbiosciences.com